A next-generation, once-weekly therapy designed to provide continuous CNP exposure...
The conversation explores how this innovation is shaping the future of dermatologic oncology, where real-time imaging, AI-driven insights, and patient-centric care models converge to deliver more effective and accessible cancer treatment...
This partnership is designed to remove that bottleneck by combining Pillar's portfolio of oncoReveal NGS-based kitted panels with CellCarta's global clinical trial testing execution...
The newly renovated space now supports more than 150 students across 34 fully equipped workstations...
Chart Chat for Nursing provides nurses with instant, citation-backed patient context from inside the EHR...
VASCADE MVP XL is now approved for larger sheaths used in market-leading PFA and LAAC technologies...
A global randomised trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone...
The Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion....
This significant achievement underscores the high order of cardiac surgical expertise, advanced pre-operative planning...
This first-in-human implantation highlights how purpose-built technology can transform care for our smallest patients...
